CODEBASE TO INVEST IN COMPANY DEVELOPING HYDROXYCHLOROQUINE TRANSDERMAL TREATMENT

VANCOUVER, BC, CANADA (April 16th, 2020) – Codebase Ventures Inc. ("Codebase" or the "Company") (CSE: CODE - FSE: C5B – OTCQB: BKLLF), an investment company, is excited to announce that it has finalized a definitive agreement as of April 15th, 2020, securing the rights to an innovative drug delivery system for hydroxychloroquine.

Sign up to receive updates

By providing your e-mail address, you are consenting to receive press releases and other information relating to Codebase Ventures Inc. You may withdraw your consent at any time by using the unsubscribe feature.